secwatch / observer
8-K filed June 11, 2025, 7:59 PM ET CIK 0001496323
other material confidence high sentiment negative materiality 0.75

IGM Biosciences, Inc.: Nasdaq/NYSE listing notice — IGM Biosciences receives Nasdaq non-compliance notice for MVLS below $50M

IGM Biosciences, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

IGM Biosciences, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
market value
Rules
5450(b)(2)(A)
Exact text from the filing
June 6, 2025, IGM Biosciences, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is no longer in compliance with the minimum Market Value of Listed Securities (“MVLS”) of $50,000,000 required for continued listing on The Nasdaq Global Select Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”). The Notice has no effect at this time on the listing of the Company’s common stock (the “Common Stock”), which continues to trade on The Nasdaq Global Select Market under the symbol “IGMS”. In
View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR
accession 0000950170-25-084924
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.